These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35128752)

  • 1. UBE2L3 promotes squamous cell carcinoma progression in the oral cavity and hypopharynx via activating the NF-κB signaling by increasing IκBα degradation.
    Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
    Cell Biol Int; 2022 May; 46(5):806-818. PubMed ID: 35128752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRELP inhibits the progression of oral squamous cell carcinoma via inactivation of the NF-κB pathway.
    Sun X; Chai L; Wang B; Zhou J
    Arch Oral Biol; 2024 Nov; 167():106068. PubMed ID: 39151326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
    Chang XS; Zhu J; Yang T; Gao Y
    Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitor of Growth 4 (ING4) Plays a Tumor-repressing Role in Oral Squamous Cell Carcinoma via Nuclear Factor Kappa-B (NF-kB)/DNA Methyltransferase 1 (DNMT1) Axis-mediated Regulation of Aldehyde Dehydrogenase 1A2 (ALDH1A2).
    Cui Z; Sun S; Li J; Li J; Sha T; He J; Zuo L
    Curr Cancer Drug Targets; 2022; 22(9):771-783. PubMed ID: 35388759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers.
    Freudlsperger C; Bian Y; Contag Wise S; Burnett J; Coupar J; Yang X; Chen Z; Van Waes C
    Oncogene; 2013 Mar; 32(12):1549-59. PubMed ID: 22641218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOXA1 silencing inhibits cisplatin resistance of oral squamous cell carcinoma cells via IκB/NF-κB signaling pathway.
    Zhu R; Mao Y; Xu X; Li Y; Zheng J
    Anticancer Drugs; 2024 Jul; 35(6):492-500. PubMed ID: 38477942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Non-Coding RNA NKILA Reduces Oral Squamous Cell Carcinoma Development Through the NF-KappaB Signaling Pathway.
    Hu D; Zhong T; Dai Q
    Technol Cancer Res Treat; 2020; 19():1533033820960747. PubMed ID: 33143574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-626 Inhibition Enhanced the Radiosensitivity to Oral Squamous Cell Carcinoma via the Downregulation of Nuclear Factor Kappa-B Signaling.
    Ma J; Na S; Wang P; Li J; He S; Liu F
    Cancer Biother Radiopharm; 2024 Mar; 39(2):144-152. PubMed ID: 35549438
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
    Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
    Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircZDBF2 up-regulates RNF145 by ceRNA model and recruits CEBPB to accelerate oral squamous cell carcinoma progression via NFκB signaling pathway.
    Rong L; Chen B; Liu K; Liu B; He X; Liu J; Li J; He M; Zhu L; Liu K; Shi X; Shuai Y; Jin L
    J Transl Med; 2022 Apr; 20(1):148. PubMed ID: 35365168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSPAN15 interacts with BTRC to promote oesophageal squamous cell carcinoma metastasis via activating NF-κB signaling.
    Zhang B; Zhang Z; Li L; Qin YR; Liu H; Jiang C; Zeng TT; Li MQ; Xie D; Li Y; Guan XY; Zhu YH
    Nat Commun; 2018 Apr; 9(1):1423. PubMed ID: 29650964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
    Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
    Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of lncRNA HCG11 promotes cell proliferation of oral squamous cell carcinoma through sponging miR-455-5p.
    Wu J; Li Y; Liu J; Xu Y
    J Gene Med; 2021 Mar; 23(3):e3293. PubMed ID: 33151000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism and Disease Association With a Ubiquitin Conjugating E2 Enzyme: UBE2L3.
    Zhang X; Huo C; Liu Y; Su R; Zhao Y; Li Y
    Front Immunol; 2022; 13():793610. PubMed ID: 35265070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-145-5p Suppresses Tumor Cell Migration, Invasion and Epithelial to Mesenchymal Transition by Regulating the Sp1/NF-κB Signaling Pathway in Esophageal Squamous Cell Carcinoma.
    Mei LL; Wang WJ; Qiu YT; Xie XF; Bai J; Shi ZZ
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28832500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBE2S activates NF-κB signaling by binding with IκBα and promotes metastasis of lung adenocarcinoma cells.
    Ho JY; Lu HY; Cheng HH; Kuo YC; Lee YA; Cheng CH
    Cell Oncol (Dordr); 2021 Dec; 44(6):1325-1338. PubMed ID: 34582005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-146a-5p inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells by regulating NF-κB signaling pathway.
    Zhu FY; Gan CW; Wang MX; Sun BC; Li FJ; Qiu YH; Wang K
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3717-3723. PubMed ID: 32329848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-186-5p inhibits the progression of oral squamous cell carcinoma by targeting ITGA6 to impair the activity of the PI3K/AKT pathway.
    Chen M; Zhang J
    J Oral Pathol Med; 2022 Apr; 51(4):322-331. PubMed ID: 35201653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA BANCR promotes oral squamous cell carcinoma progression via regulating Rab1A signaling.
    Li W; Xu X; Ma Z; Shen P; Cheng B; Xia J; Li Y
    J Oral Pathol Med; 2023 Sep; 52(8):727-737. PubMed ID: 37433101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.